RNC Capital Management’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $53.2M | Buy |
505,611
+761
| +0.2% | +$71.4K | 2.42% | 18 |
|
|
2025
Q3 | $42.4M | Buy |
504,850
+133,326
| +36% | +$11M | 1.95% | 27 |
|
|
2025
Q2 | $29.4M | Sell |
371,524
-22,163
| -6% | -$1.76M | 1.43% | 33 |
|
|
2025
Q1 | $35.3M | Buy |
393,687
+105,798
| +37% | +$9.88M | 1.8% | 30 |
|
|
2024
Q4 | $28.6M | Buy |
287,889
+258,910
| +893% | +$26.7M | 1.53% | 32 |
|
|
2024
Q3 | $3.59M | Hold |
28,979
| – | – | 0.2% | 63 |
|
|
2024
Q2 | $3.59M | Buy |
28,979
+2,711
| +10% | +$349K | 0.2% | 63 |
|
|
2024
Q1 | $3.47M | Buy |
26,268
+4,753
| +22% | +$586K | 0.2% | 61 |
|
|
2023
Q4 | $2.35M | Sell |
21,515
-5,750
| -21% | -$597K | 0.14% | 67 |
|
|
2023
Q3 | $2.81M | Sell |
27,265
-881
| -3% | -$95K | 0.17% | 63 |
|
|
2023
Q2 | $3.25M | Buy |
28,146
+19,669
| +232% | +$2.23M | 0.18% | 71 |
|
|
2023
Q1 | $902K | Buy |
8,477
+166
| +2% | +$17.9K | 0.05% | 109 |
|
|
2022
Q4 | $922K | Sell |
8,311
-531
| -6% | -$54.3K | 0.05% | 111 |
|
|
2022
Q3 | $762K | Sell |
8,842
-383
| -4% | -$34.2K | 0.05% | 111 |
|
|
2022
Q2 | $841K | Sell |
9,225
-147
| -2% | -$13K | 0.05% | 111 |
|
|
2022
Q1 | $769K | Sell |
9,372
-1,070
| -10% | -$84.4K | 0.04% | 115 |
|
|
2021
Q4 | $800K | Buy |
10,442
+1,199
| +13% | +$95.5K | 0.04% | 112 |
|
|
2021
Q3 | $694K | Sell |
9,243
-351
| -4% | -$26.7K | 0.04% | 117 |
|
|
2021
Q2 | $746K | Sell |
9,594
-461
| -5% | -$34.3K | 0.04% | 109 |
|
|
2021
Q1 | $740K | Sell |
10,055
-4,080
| -29% | -$301K | 0.04% | 107 |
|
|
2020
Q4 | $1.1M | Sell |
14,135
-1,809
| -11% | -$138K | 0.07% | 101 |
|
|
2020
Q3 | $1.26M | Sell |
15,944
-712
| -4% | -$55.8K | 0.09% | 88 |
|
|
2020
Q2 | $1.23M | Sell |
16,656
-302
| -2% | -$22.7K | 0.09% | 79 |
|
|
2020
Q1 | $1.25M | Sell |
16,958
-1,054
| -6% | -$82.8K | 0.11% | 84 |
|
|
2019
Q4 | $1.56M | Buy |
18,012
+2,350
| +15% | +$193K | 0.1% | 83 |
|
|
2019
Q3 | $1.26M | Buy |
15,662
+75
| +0.5% | +$6.01K | 0.09% | 81 |
|
|
2019
Q2 | $1.25M | Buy |
15,587
+193
| +1% | +$14.8K | 0.09% | 80 |
|
|
2019
Q1 | $1.22M | Sell |
15,394
-1,838
| -11% | -$137K | 0.09% | 76 |
|
|
2018
Q4 | $1.26M | Buy |
17,232
+679
| +4% | +$47.9K | 0.1% | 71 |
|
|
2018
Q3 | $1.12M | Buy |
16,553
+107
| +0.7% | +$6.82K | 0.07% | 76 |
|
|
2018
Q2 | $953K | Sell |
16,446
-3,514
| -18% | -$198K | 0.07% | 79 |
|
|
2018
Q1 | $1.04M | Buy |
19,960
+2,380
| +14% | +$129K | 0.08% | 76 |
|
|
2017
Q4 | $944K | Buy |
17,580
+1,159
| +7% | +$64.3K | 0.07% | 80 |
|
|
2017
Q3 | $1M | Sell |
16,421
-6
| -0% | -$364 | 0.08% | 72 |
|
|
2017
Q2 | $1M | Buy |
16,427
+215
| +1% | +$13.1K | 0.08% | 72 |
|
|
2017
Q1 | $983K | Sell |
16,212
-2,521
| -13% | -$153K | 0.08% | 71 |
|
|
2016
Q4 | $1.05M | Buy |
18,733
+1,227
| +7% | +$71.8K | 0.09% | 80 |
|
|
2016
Q3 | $1.04M | Sell |
17,506
-631
| -3% | -$36.9K | 0.09% | 74 |
|
|
2016
Q2 | $997K | Buy |
18,137
+252
| +1% | +$13.4K | 0.09% | 76 |
|
|
2016
Q1 | $903K | Buy |
17,885
+496
| +3% | +$24.3K | 0.09% | 77 |
|
|
2015
Q4 | $876K | Buy |
17,389
+6,280
| +57% | +$317K | 0.09% | 81 |
|
|
2015
Q3 | $524K | Sell |
11,109
-1,100
| -9% | -$58.4K | 0.05% | 80 |
|
|
2015
Q2 | $663K | Sell |
12,209
-706
| -5% | -$39.6K | 0.06% | 74 |
|
|
2015
Q1 | $708K | Sell |
12,915
-428
| -3% | -$24.2K | 0.06% | 71 |
|
|
2014
Q4 | $723K | Buy |
13,343
+651
| +5% | +$36.3K | 0.06% | 77 |
|
|
2014
Q3 | $718K | Sell |
12,692
-2,223
| -15% | -$125K | 0.06% | 72 |
|
|
2014
Q2 | $823K | Sell |
14,915
-288
| -2% | -$15.7K | 0.07% | 71 |
|
|
2014
Q1 | $824K | Sell |
15,203
-12,656
| -45% | -$655K | 0.07% | 72 |
|
|
2013
Q4 | $1.33M | Sell |
27,859
-619,156
| -96% | -$28.3M | 0.12% | 67 |
|
|
2013
Q3 | $29.4M | Buy |
647,015
+26,478
| +4% | +$1.21M | 2.96% | 13 |
|
|
2013
Q2 | $27.5M | Buy |
+620,537
| New | +$27.7M | 2.91% | 15 |
|
Other funds holding MRK
RNC Capital Management's MRK Position: Q4 2025 in Review
RNC Capital Management increased its Merck (MRK) stake by 0.15% in Q4 2025, buying an estimated $71.4K and bringing the position to 505,611 shares worth $53.2M. The position accounts for 2.42% of the portfolio, ranked #18.
RNC Capital Management first reported a position in MRK in Q2 2013 and has held it in 51 quarters since. 3,651 funds tracked by Wall St. Rank hold MRK as of Q4 2025.
- RNC Capital Management held 505,611 shares of Merck worth $53.2M as of Q4 2025.
- RNC Capital Management bought 761 Merck shares in Q4 2025, an estimated $71.4K.
- Merck made up 2.42% of RNC Capital Management's portfolio in Q4 2025, its #18 holding.
- RNC Capital Management first reported a position in Merck in Q2 2013 and has held it in 51 quarters since.
- 3,651 funds tracked by Wall St. Rank held Merck as of Q4 2025.
Based on RNC Capital Management's 13F filing for Q4 2025, filed 3 Feb 2026.